Niki BioSolutions, Inc.: 10% owner Sheinerman Kira received 8,000 shares

What happened

• Sheinerman Kira, listed as a 10% owner, received 8,000 derivative shares (grant/award) on Jul 22, 2026. The filing reports a price of $0.00 per share and a total value of $0.

Key details

• Transaction date: Jul 22, 2026; transaction type: Grant/award (code A); price: $0.00 per share.
• Number of shares acquired: 8,000 (derivative).
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Filing date: Oct 21, 2026 (period of report Jul 22, 2026).
• Footnote F1 (from the filing): "The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger."

Why it may matter

• This was a grant of derivative shares (options), not an exercise or a sale; the filing shows a vesting schedule in footnote F1.
• 10% owner: the insider is listed as a 10% owner, which is a large holder classification rather than an executive title.
• A filing does not show why the insider traded or why the company acted.